|
⚲
|
| Keyboard |
| Enavate Sciences GP LLC
✚
|
|
|---|---|
| CIK # | 0001953107 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Sionna Therapeutics Inc | 99.3 | ||
| Immunome Inc | 79.0 | ||
| Zenas Biopharma Inc | 76.6 | ||
| Olivia Ventures Inc | 41.2 | ||
| Helix Acquisition Corp II | 23.5 | ||
| Upstream Bio Inc | 22.1 | ||
| Camp4 Therapeutics Corp | 9.7 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001953107] | |
| 3 | [0001953107] | |
| 4 | [0001953107] | |
| SC 13D | [0001953107] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Enavate Sciences GP LLC | Sionna Therapeutics Inc | [2025-02-18] |
| Enavate Sciences GP LLC | Camp4 Therapeutics Corp | [2024-10-22] |
| Enavate Sciences GP LLC | Zenas Biopharma Inc | [2024-09-23] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Camp4 Therapeutics Corp | |
| Enavate Sciences GP LLC | |
| Everest Aggregator LP | |
| Zebra Aggregator LP | |
| Zenas BioPharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 2,422,166 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 1,363,636 | $11.00 | 14,999,996 |
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 27,166,530 | ||
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Conversion | 2,879,006 | ||
|
Zenas BioPharma Inc ZBIO
Series B Preferred Stock · derivative
|
2024-09-16 | Conversion | 10,474,889 | ||
|
Zenas BioPharma Inc ZBIO
Common Stock
|
2024-09-16 | Buy | 882,353 | $17.00 | 15,000,001 |
|
Zenas BioPharma Inc ZBIO
Series C Preferred Stock · derivative
|
2024-09-16 | Conversion | 14,523,821 |